19

резултат(и)

Дума(и)
Вид публикация
Област на политиките
Автор
Дата

Limits on exposure to carcinogens and mutagens at work: Fourth proposal

29-10-2020

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps and has now become a continuous process. Following on from three previous legislative amendments, which covered a total of 26 priority chemical agents, the present (fourth) proposal addresses an additional three. The proposal was announced as ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps and has now become a continuous process. Following on from three previous legislative amendments, which covered a total of 26 priority chemical agents, the present (fourth) proposal addresses an additional three. The proposal was announced as one of the first measures of the Commission's commitment to fight cancer under the forthcoming Europe's Beating Cancer plan. Broad discussions with scientists and social partners fed into all four proposals. The Commission's feedback period on the proposal will run until 20 November 2020. While broadly welcoming the proposal, professional organisations, trade unions and patient groups would like carcinogenic and mutagenic hazardous medicines as well as substances toxic for reproduction to be brought within the scope of the current proposal. The legislative process is in its early stages. In Parliament, the Committee on Employment and Social Affairs is in charge of the file. The working party on social questions is dealing with it in the Council. First edition. The 'EU Legislation in Progress' briefings are updated at key stages throughout the legislative procedure.

Limits on exposure to carcinogens and mutagens at work: Third proposal

30-08-2019

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three ...

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three proposals. Reacting to the Commission's set of measures as a whole, trade unions have acknowledged the importance of further improving the existing framework. Actors on the employers' side have underlined the need to ensure that values are proportionate and feasible in terms of technical implementation. After adoption by the Parliament and Council, in March and May respectively, based on a text agreed in trilogue in January 2019, the final act was signed by the presidents of the co-legislators on 5 June 2019. Directive (EU) 2019/983 entered into force on 10 July 2019 and is to be transposed into national law within two years, by 11 July 2021. Third edition. The 'EU Legislation in Progress' briefings are updated at key stages throughout the legislative procedure.

Protecting workers against carcinogens and mutagens: Third proposal

20-03-2019

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the ...

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the March II plenary session.

Limits on exposure to carcinogens and mutagens at work: Second proposal

15-03-2019

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade unions and employers welcomed the current proposal. Trilogue agreement was reached on 11 October 2018. As proposed by the European Parliament, diesel engine exhaust emissions were included in the scope of the directive. After completion of the legislative procedure, the final act was signed by the presidents of the co-legislators on 16 January 2019. Directive (EU) 2019/130 entered into force on 20 February 2019 and is to be transposed into national laws within two years, by 20 February 2021 at the latest. Third edition. The ‘EU Legislation in Progress’ briefings are updated at key stages throughout the legislative procedure.

Protection of workers from exposure to carcinogens or mutagens: Third proposal

17-12-2018

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research ...

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research centres, publishers and international organisations, making the overall analysis sufficiently convincing and robust. As regards the limitations of the analysis, which are transparently acknowledged, the analysis carried out by the external contractors and endorsed in the IA recognises that the full current and future disease burden deriving from historic exposures to cadmium and beryllium is not captured; consequently, the disease burdens may be underestimated. As regards the estimated number of workers exposed to cadmium, the value of 10 000 workers considered by the external contractors for their modelling (in addition to a higher value of 30 000), and taken over in the IA, is coherently justified in light of the recognised wide divergences among the different estimates. This value appears to be reasonable, based on the availability of data at national and EU level, and the way some of them were gathered. As regards the estimated number of workers exposed to beryllium, the figure of 54 071 workers exposed in the EU 28 (excluding the construction sector) identified by the external contractor and used in the IA appears to be plausible, based on the justifications provided. However, it is acknowledged that higher exposure levels would imply higher costs and benefits at all target OEL values.

Protecting workers against carcinogens and mutagens: Second proposal

05-12-2018

The European Commission has started a phased process to amend Directive 2004/37/EC (Carcinogens and Mutagens Directive, CMD), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The second proposal to amend the CMD addresses a further seven agents. It is among the Joint Declaration initiatives Parliament, Council and Commission have committed to handle with priority. The agreement on the proposal reached ...

The European Commission has started a phased process to amend Directive 2004/37/EC (Carcinogens and Mutagens Directive, CMD), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The second proposal to amend the CMD addresses a further seven agents. It is among the Joint Declaration initiatives Parliament, Council and Commission have committed to handle with priority. The agreement on the proposal reached after trilogue negotiations now needs a confirmation vote, expected to take place during the December plenary session.

Protection of workers from exposure to carcinogens or mutagens: third proposal

27-06-2018

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent ...

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent with the approach followed in two previous amendments of the directive. The analysis of impacts focuses on the economic and social dimension, mainly health, consistently with the manner in which the problem has been defined. Environmental impacts are assessed to be broadly negligible: considering that the IA is dealing with carcinogenic chemical substances, this would have perhaps required further justification. The IA acknowledges a general issue regarding, inter alia, the availability of data on the number of workers exposed, and the scarce and not always sufficiently robust epidemiological evidence. The methodological annex does not provide information regarding how the multi criteria analysis has been performed. Finally, the IA appears to have addressed most of the RSB's recommendations and the legislative proposal appears to be consistent with the analysis carried out in the IA.

Authorisation of pesticides in the EU: With a focus on glyphosate

01-02-2018

In the European Union, plant protection products, often referred to as 'pesticides', are subject to a dual approval process: active substances are approved at European Union (EU) level, provided they meet a number of criteria. Commercial plant protection products containing one or more active substances are subsequently authorised at Member State level if they satisfy certain conditions. A controversy has emerged since 2015 over the renewal of the approval of glyphosate. One of the active substances ...

In the European Union, plant protection products, often referred to as 'pesticides', are subject to a dual approval process: active substances are approved at European Union (EU) level, provided they meet a number of criteria. Commercial plant protection products containing one or more active substances are subsequently authorised at Member State level if they satisfy certain conditions. A controversy has emerged since 2015 over the renewal of the approval of glyphosate. One of the active substances most commonly found in broad-spectrum herbicides in the world, glyphosate is mainly used in agriculture. The controversy started as a result of diverging assessments of its carcinogenicity: the International Agency for Research on Cancer, a branch of the World Health Organization, classified glyphosate as probably carcinogenic to humans, while the European Food Safety Authority found it unlikely to pose a carcinogenic hazard to humans. The European Chemicals Agency later concluded that glyphosate did not classify as a carcinogen. Several national authorities outside the EU also came to the same conclusion. The European Commission eventually renewed the approval of glyphosate for five years in December 2017. The views of stakeholders and Member States on the topic have been strongly divided. The European Parliament has called for phasing out all uses of glyphosate by the end of 2022. Parliament is expected to vote, in February 2018, on the creation of a special committee on the Union's authorisation procedure for pesticides.

Limits on exposure to carcinogens and mutagens at work

22-01-2018

The European Commission proposes to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer-causing chemical agents. According to the Commission, this would improve workers' health protection, increase the effectiveness of the EU framework and promote clarity for economic operators. Overall, the proposal received a broad welcome from stakeholders. After completion of the legislative procedure at first reading in ...

The European Commission proposes to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer-causing chemical agents. According to the Commission, this would improve workers' health protection, increase the effectiveness of the EU framework and promote clarity for economic operators. Overall, the proposal received a broad welcome from stakeholders. After completion of the legislative procedure at first reading in the European Parliament and the Council, the presidents of the co-legislators signed the final act on 12 December 2017. The directive applies as from 16 January 2018.

Protection of workers from carcinogens or mutagens at work: Exposure limit values

23-10-2017

The European Commission proposes to amend Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (the Carcinogens and Mutagens Directive, CMD) by expanding its scope and by including and/or revising occupational exposure limit values for 13 cancer- and mutation-causing chemicals. Parliament is due to vote on the proposal during the October II plenary.

The European Commission proposes to amend Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (the Carcinogens and Mutagens Directive, CMD) by expanding its scope and by including and/or revising occupational exposure limit values for 13 cancer- and mutation-causing chemicals. Parliament is due to vote on the proposal during the October II plenary.

Предстоящи събития

26-01-2021
Public hearing on Co-management of EU fisheries at local level
Изслушване -
PECH
26-01-2021
The impact of Brexit on the level playing field in the area of taxation
Изслушване -
FISC
27-01-2021
EPRS online policy roundtable: President Biden’s first 100 days [...]
Други мероприятия -
EPRS

Партньори